Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

DREAM Inhibitors

DREAM inhibitors belong to a specific chemical class of compounds that have been studied and designed to selectively target and inhibit the activity of DREAM, also known as Downstream Regulatory Element Antagonist Modulator. DREAM is a calcium-binding protein that functions as a transcriptional repressor, modulating gene expression in response to intracellular calcium levels. It plays a role in various cellular processes, including neuronal signaling and gene regulation. Inhibition of DREAM aims to disrupt its binding and repressive interactions with downstream regulatory elements in the DNA, potentially modulating the transcriptional activity of target genes. The chemical structures of DREAM inhibitors can vary, including synthetic small-molecule compounds and natural products that specifically interact with DREAM and hinder its calcium-dependent gene regulatory function. Researchers have explored various strategies to target DREAM and attenuate its effects on gene expression in neurons and other cells. The study of DREAM inhibitors provides valuable insights into the complex regulatory mechanisms governing calcium-mediated gene regulation and cellular physiology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Repaglinide

135062-02-1sc-219959
sc-219959A
sc-219959B
100 mg
250 mg
1 g
$215.00
$414.00
$1331.00
3
(0)

Repaglinide is a drug used for type 2 diabetes, but it has also shown inhibitory effects on DREAM, particularly in modulating calcium-regulated gene expression.